ArticleCancer chemotherapy and pharmacology2026

Biological frailty and chemotherapy dose intensity independently predict survival in older adults with Stage II-III colon cancer.

Ahmet Burak Ağaoğlu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.